Where I see patients (1)
My reviews
5.0
Selected research
-
The Irreversible FLT3 Inhibitor FF-10101 Is Active Against a Diversity of FLT3 Inhibitor Resistance Mechanisms.
Molecular cancer therapeutics
-
Outcomes of allogeneic transplantation after hypomethylating agents with venetoclax in acute myeloid leukemia.
American journal of hematology
-
SOHO State of the Art Updates and Next Questions: Novel Transplant and Post-Transplant Options in Acute Lymphoblastic Leukemia.
Clinical lymphoma, myeloma & leukemia
Clinical trials
Contact me
- Request appointment
- Refer a patient
- (415) 353-2421